Post-treatment Effects of Ivermectin (IVM) or Diethylcarbamazine (DEC) in Loiasis

NCT01593722 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

155

Enrollment

NIH

Sponsor class

Conditions

Loiasis

Interventions

DRUG: Diethylcarbamazine
DRUG: Ivermectin

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)